Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 315 (LINC00315) is a human long intergenic non-coding RNA gene located on chromosome 21 (also called C21orf93, NCRNA00315, or LOC124905040)[1]. This RNA does not encode a protein but may play a regulatory role at the RNA level, possibly affecting gene expression in *cis* or *trans* as is typical for the lincRNA family[3]. Some evidence implicates LINC00315 in cancer biology, such as tumor progression and cell proliferation, but detailed molecular or functional annotation for this specific lncRNA remains sparse[1]. There is no evidence LINC00315 is a classic therapeutic target, such as a receptor, enzyme, or transporter[1][3]. It is most accurately classified as a member of the lincRNA (long intergenic non-coding RNA) subclass, which may exert regulatory functions but is not traditionally druggable. No clinically validated drugs, mechanisms of action, or safety concerns are currently associated with LINC00315.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 315 (LINC00315).